Showing results (61-70 of 319) with videos related to
Sort By:
Pageof 32
Cancer Science|December 29, 2017
Pembrolizumab in Asia-Pacific patients with advanced head and neck squamous cell carcinoma: Analyses from KEYNOTE-012Makoto Tahara, Kei Muro, Yasuhisa Hasegawa, et al.Archives of Surgery (Chicago, Ill. : 1960)|November 19, 2008
Cyclooxygenase-2 expression in pretreatment biopsy as a predictor of tumor responses after preoperative chemoradiation in rectal cancerByung Soh Min, Yoon Jung Choi, Hong Ryull Pyo, et al.Asian Pacific Journal of Cancer Prevention : APJCP|April 5, 2012
Genetic analysis of liver metastatic cell lines with different metastatic potentialHong-Hua Sun, Hai Cui, Yong-Min Jin, et al.Pathology|May 7, 2014
Angiogenic factor thymidine phosphorylase associates with angiogenesis and lymphangiogenesis in the intestinal-type gastric cancerXianglan Zhang, Zhenlong Zheng, You Keun Shin, et al.Biochimica Et Biophysica Acta|July 3, 2007
Molecular basis of the differences between normal and tumor tissues of gastric cancerSanghwa Yang, Jihye Shin, Kyu Hyun Park, et al.Journal of Gastroenterology and Hepatology|December 5, 2008
Effect of being overweight on postoperative morbidity and long-term surgical outcomes in proximal gastric carcinomaSung Jin Oh, Woo Jin Hyung, Chen Li, et al.Oncology|October 11, 2014
PTEN deficiency as a predictive biomarker of resistance to HER2-targeted therapy in advanced gastric cancerXianglan Zhang, Ji Soo Park, Kyu Hyun Park, et al.Cancer Research and Treatment|December 19, 2015
A Phase II Study of Gemcitabine Monotherapy in Breast Cancer Patients Refractory to Anthracycline and TaxaneJun Yong Park, Chul Kim, Joo Hyuk Sohn, et al.Journal of Cancer Research and Clinical Oncology|March 11, 2010
Identification of genes related to a synergistic effect of taxane and suberoylanilide hydroxamic acid combination treatment in gastric cancer cellsHyun Chang, Sun Young Rha, Hei-Cheul Jeung, et al.Investigational New Drugs|May 14, 2011
A phase I pharmacokinetic study of TSU-68 (a multiple tyrosine kinase inhibitor of VEGFR-2, FGF and PDFG) in combination with S-1 and oxaliplatin in metastatic colorectal cancer patients previously treated with chemotherapySang Joon Shin, Minkyu Jung, Hei-Cheul Jeung, et al.Pageof 32